References
- Aït-Khaled, N., Alarcon, E., Bissell, K., Boillot, F., Caminero, J., Chiang, C., & Dlodlo, R. (2009). Isoniazid preventive therapy for people living with HIV: Public health challenges and implementation issues. International Journal of Tuberculosis and Lung Disease, 13(8), 927–935. PMID: 19723371.
- Alsdurf, H., Hill, P. C., Matteelli, A., Getahun, H., & Menzies, D. (2016). The cascade of care in diagnosis and treatment of latent tuberculosis infection: A systematic review and meta-analysis. The Lancet Infectious Diseases, 16(11), 1269–1278. https://doi.org/10.1016/S1473-3099(16)30216-X
- Azadi, M., Bishai, D. M., Dowdy, D. W., Moulton, L. H., Cavalcante, S., Saraceni, V., Pacheco, A. G., Cohn, S., Chaisson, R. E., Durovni, B., & Golub, J. E. (2014). Cost-effectiveness of tuberculosis screening and isoniazid treatment in the TB/HIV in Rio (THRio) study. The International Journal of Tuberculosis and Lung Disease, 18(12), 1443–1448. https://doi.org/10.5588/ijtld.14.0108
- Badje, A., Moh, R., Gabillard, D., Guehi, C., Kabran, M., Ntakpe, J. B., Carrou, J. L., Kouame, G. M., Ouattara, E., Messou, E., Anzian, A., Minga, A., Gnokoro, J., Gouesse, P., Emieme, A., Toni, T.-D., Rabe, C., Sidibé, B., Nzunetu, G., … Anglaret, X. (2017). Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: Long-term follow-up of the temprano ANRS 12136 trial. The Lancet Global Health, 5(11), e1080–e1089. https://doi.org/10.1016/S2214-109X(17)30372-8
- Bajunirwe, F., Tumwebaze, F., Abongomera, G., Akakimpa, D., Kityo, C., & Mugyenyi, P. N. (2016). Identification of gaps for implementation science in the HIV prevention, qualitative study in 19 districts in Uganda. BMC Research Notes, 9(217). doi:10.1186/s13104-016-2024-4. PMID: 27074947.
- Balcells, M. E., Thomas, S. L., Godfrey-Faussett, P., & Grant, A. D. (2006). Isoniazid preventive therapy and risk for resistant tuberculosis. Emerging Infectious Diseases, 12(5), 744–751. https://doi.org/10.3201/eid1205.050681
- Bristow, C., Larson, E., Vilakazi-Nhlapo, A., Wilson, M., & KLausner, J. (2012). Scale-up of isoniazid preventive therapy in PEPFAR-assisted clinical sites in South Africa. The International Journal of Tuberculosis and Lung Disease, 16(8), 1020–1022. https://doi.org/10.5588/ijtld.11.0744
- Charalambous, S., Grant, A. D., Churchyard, G. J., Mukora, R., Schneider, H., & Fielding, K. L. (2016). Clinic-level factors influencing patient outcomes on antiretroviral therapy in primary health clinics in South Africa. AIDS, 30(7), 1099–1109. https://doi.org/10.1097/QAD.0000000000001014
- Charles, M. K., Lindegren, M. L., Wester, C. W., Blevins, M., Sterling, T. R., Dung, N. T., … Fenner, L. (2016). Implementation of tuberculosis intensive case finding, isoniazid preventive therapy, and infection control (“Three I's”) and HIV-tuberculosis service integration in lower income countries. PLoS One, 11(4), e0153243. https://doi.org/10.1371/journal.pone.0153243
- Chehab, J., Vilakazi-Nhlapo, K., Vranken, P., Peters, A., & Klausner, J. (2012). Survey of isoniazid preventive therapy in South Africa, 2011. International Journal of Tuberculosis and Lung Disease, 16(7), 903–907. https://doi.org/10.5588/ijtld.11.0722
- Churchyard, G. J., Fielding, K., Charalambous, S., Day, J. H., Corbett, E. L., Hayes, R. J., Chaisson, R. E., De Cock, K. M., Samb, B., & Grant, A. D. (2003). Efficacy of secondary isoniazid preventive therapy among HIV-infected southern africans: Time to change policy? AIDS, 17(14), 2063–2070. https://doi.org/10.1097/00002030-200309260-00007
- Fox, M., Rosen, S., Geldsetzer, P., Barnighausen, T., Negussie, E., & Beanland, R. (2016). Interventions to improve the rate or timing of initiation of antiretroviral therapy for HIV in sub-Saharan Africa: Meta-analyses of effectiveness. Journal of the International AIDS Society, 19(1), https://doi.org/10.7448/IAS.19.1.20888
- German, R. R., Lee, L. M., Horan, J. M., Milstein, R. L., Pertowski, C. A., & Waller, M. N. (2001). Updated guidelines for evaluating public health surveillance systems: Recommendations from the guidelines working group. MMWR. Recommendations and Reports, 50(Rr-13), 1–35. PMID: 18634202
- Golub, J. E., Pronyk, P., Mohapi, L., Thsabangu, N., Moshabela, M., Struthers, H., & Gray, G. E. (2011). Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: A prospective cohort. AIDS, 23(5), 631–636. https://doi.org/10.1097/QAD.0b013e328327964f
- Grant, A., Charalambous, S., Fielding, K., Day, J., Corbett, E., Chaisson, R., De Cock, K. M., Hayes, R. J., & Churchyard, G. J. (2005). Effect of routine isoniazid preventive therapy on tuberculosis incidence among HIV-infected men in South Africa: A novel randomized incremental recruitment study. JAMA, 293(22), 2719–2725. https://doi.org/10.1001/jama.293.22.2719
- Gupta, S., Granich, R., Date, A., Lepere, P., Hersh, B., Gouws, E., & Samb, B. (2014). Review of policy and status of implementation of collaborative HIV-TB activities in 23 high-burden countries. The International Journal of Tuberculosis and Lung Disease, 18(10), 1149–1158. https://doi.org/10.5588/ijtld.13.0889
- Harvey, G., Loftus-Hills, A., Rycroft-Malone, J., Titchen, A., Kitson, A., McCormack, B., & Seers, K. (2002). Getting evidence into practice: The role and function of facilitation. Journal of Advanced Nursing, 37(6), 577–588. https://doi.org/10.1046/j.1365-2648.2002.02126.x
- Heaman, M. I., Sword, W., Elliott, L., Moffatt, M., Helewa, M. E., Morris, H., … Cook, C. (2015). Barriers and facilitators related to use of prenatal care by inner-city women: Perceptions of health care providers. BMC Pregnancy and Childbirth, 15(2). https://doi.org/10.1186/s12884-015-0431-5
- Hutchinson, E., Droti, B., Gibb, D., Chishinga, N., Hoskins, S., Phiri, S., & Parkhurst, J. (2011). Translating evidence into policy in low-income countries: Lessons from co-trimoxazole preventive therapy. Bulletin of the World Health Organization, 89(4), 312–316. https://doi.org/10.2471/BLT.10.077743
- Institute of Medicine Committee on Quality of Health Care in America. (2001). Crossing the quality chasm: A new health system for the 21st century. National Academies Press (US) Copyright 2001 by the National Academy of Sciences. All rights reserved.
- Jacobson, K., Moll, A., Friedland, G., & Shenoi, S. (2015). Successful tuberculosis treatment outcomes among HIV/TB coinfected patients down-referred from a district hospital to primary health clinics in rural South Africa. PLoS One, 10(5).PMID: 28147705 PMCID: PMC5545149. DOI:https://doi.org/10.1080/09540121.2017.1283390
- Jacobson, K. B., Niccolai, L., Mtungwa, N., Moll, A. P., & Shenoi, S. V. (2017). “It’s about my life”: Facilitators of and barriers to isoniazid preventive therapy completion among people living with HIV in rural South Africa. AIDS Care, 1–7. https://doi.org/10.1080/09540121.2017.1283390
- Kitson, A., Harvey, G., & McCormack, B. (1998). Enabling the implementation of evidence based practice: A conceptual framework. Quality and Safety in Health Care, 7(3), 149–158. https://doi.org/10.1136/qshc.7.3.149
- Kitson, A. L., Rycroft-Malone, J., Harvey, G., McCormack, B., Seers, K., & Titchen, A. (2008). Evaluating the successful implementation of evidence into practice using the PARiHS framework: Theoretical and practical challenges. Implementation Science, 3(1), 1. https://doi.org/10.1186/1748-5908-3-1
- Kufa, T., Chihota, V., Charalambous, S., & Churchyard, G. J. (2014). Isoniazid preventive therapy use among patients on antiretroviral therapy: A missed opportunity. International Journal of Tuberculosis and Lung Disease, 18(3), 312–314 (313). https://doi.org/10.5588/ijtld.13.0505
- Lee, C. Y., Chi, M. J., Yang, S. L., Lo, H. Y., & Cheng, S. H. (2015). Using financial incentives to improve the care of tuberculosis patients. The American Journal of Managed Care, 21(1), e35–e42. PMID: 25880266.
- Lester, R., Hamilton, R., Charalambous, S., Dwadwa, T., Chandler, C., Churchyard, G., & Grant, A. (2010). Barriers to implementation of isoniazid preventive therapy in HIV clinics: A qualitative study. AIDS, 24(Suppl 5), S45–S48. https://doi.org/10.1097/01.aids.0000391021.18284.12
- Mars, M. (2014). Tele-education in South Africa. Frontiers in Public Health, 2, 173. https://doi.org/10.3389/fpubh.2014.00173
- McCormack, B., Kitson, A., Harvey, G., Rycroft-Malone, J., Titchen, A., & Seers, K. (2002). Getting evidence into practice: The meaning of ‘context’. Journal of Advanced Nursing, 38(1), 94–104. https://doi.org/10.1046/j.1365-2648.2002.02150.x
- Menzies, D., Adjobimey, M., Ruslami, R., Trajman, A., Sow, O., Kim, H., Obeng Baah, J., Marks, G. B., Long, R., Hoeppner, V., Elwood, K., Al-Jahdali, H., Gninafon, M., Apriani, L., Koesoemadinata, R. C., Kritski, A., Rolla, V., Bah, B., Camara, A., … Benedetti, A. (2018). Four months of rifampin or nine months of isoniazid for latent tuberculosis in adults. New England Journal of Medicine, 379(5), 440–453. https://doi.org/10.1056/NEJMoa1714283
- Mlotshwa, M., Smit, S., Williams, S., Reddy, C., & Medina-Marino, A. (2017). Evaluating the electronic tuberculosis register surveillance system in Eden District, Western Cape, South Africa, 2015. Global Health Action, 10(1), 1360560. https://doi.org/10.1080/16549716.2017.1360560
- Moolphate, S., Lawpoolsri, S., Pungrassami, P., Sanguanwongse, N., Yamada, N., & Kaewkungwal, J. (2013). Barriers to and motivations for the implementation of a treatment programme for latent tuberculosis infection using isoniazid for people living with HIV, in upper northern Thailand. Global Journal of Health Science, 5(4), 60–70. https://doi.org/10.5539/gjhs.v5n4p60
- Munro, S. A., Lewin, S. A., Smith, H. J., Engel, M. E., Fretheim, A., & Volmink, J. (2007). Patient adherence to tuberculosis treatment: A systematic review of qualitative research. PLoS Medicine, 4(7), e238. https://doi.org/10.1371/journal.pmed.0040238
- Munthali, A. C., Ngwira, B. M., & Taulo, F. (2015). Exploring barriers to the delivery of cervical cancer screening and early treatment services in Malawi: Some views from service providers. Patient Preference and Adherence, 9, 501–508. https://doi.org/10.2147/PPA.S69286
- Page-Shipp, L., Voss De Lima, Y., Clouse, K., De Vos, J., Evarts, L., Bassett, J., Sanne, I., & Van Rie, A. (2012). TB/HIV integration at primary care level: A quantitative assessment at 3 clinics in johannesburg, South Africa. South African Journal of HIV Medicine, 13(3), 138–143. https://doi.org/10.4102/sajhivmed.v13i3.127
- Pantoja, T., Opiyo, N., Lewin, S., Paulsen, E., Ciapponi, A., Wiysonge, C. S., … Oxman, A. D. (2017). Implementation strategies for health systems in low-income countries: An overview of systematic reviews. Cochrane Database of Systematic Reviews, 9, Cd011086. https://doi.org/10.1002/14651858.CD011086.pub2
- Powell, B. J., Waltz, T. J., Chinman, M. J., Damschroder, L. J., Smith, J. L., Matthieu, M. M., Proctor, E. K., & Kirchner, J. E. (2015). A refined compilation of implementation strategies: Results from the expert recommendations for implementing change (ERIC) project. Implementation Science, 10(1), 21. https://doi.org/10.1186/s13012-015-0209-1
- Rangaka, M. X., Cavalcante, S. C., Marais, B. J., Thim, S., Martinson, N. A., Swaminathan, S., & Chaisson, R. E. (2015). Controlling the seedbeds of tuberculosis: Diagnosis and treatment of tuberculosis infection. The Lancet, 386(10010), 2344–2353. https://doi.org/10.1016/S0140-6736(15)00323-2
- Republic of South Africa Department of Health. (2010). Guidelines for tuberculosis preventive therapy among HIV infected individuals in South Africa.
- Rutherford, M., Hill, P., Triasih, R., Sinfield, R., van Crevel, R., & Graham, S. (2012). Preventive therapy in children exposed to mycobacterium tuberculosis: Problems and solutions. Tropical Medicine & International Health, 17(10), 1264–1273. https://doi.org/10.1111/j.1365-3156.2012.03053.x
- Rycroft-Malone, J., Seers, K., Titchen, A., Harvey, G., Kitson, A., & McCormack, B. (2004). What counts as evidence in evidence-based practice? Journal of Advanced Nursing, 47(1), 81–90. https://doi.org/10.1111/j.1365-2648.2004.03068.x
- Schuster, R. C., de Sousa, O., Reme, A. K., Vopelak, C., Pelletier, D. L., Johnson, L. M., Mbuya, M., Pinault, D., & Young, S. L. (2018). Performance-based financing empowers health workers delivering prevention of vertical transmission of HIV services and decreases desire to leave in Mozambique. International Journal of Health Policy and Management, 7(7), 630–644. https://doi.org/10.15171/ijhpm.2017.137
- Singh, A. R., Kharate, A., Bhat, P., Kokane, A. M., Bali, S., Sahu, S., … Kumar, A. M. (2017). Isoniazid preventive therapy among children living with tuberculosis patients: Is It working? A mixed-method study from bhopal, India. Journal of Tropical Pediatrics, 63(4), 274–285. https://doi.org/10.1093/tropej/fmw086
- Sterling, T. R., Scott, N. A., Miro, J. M., Calvet, G., La Rosa, A., Infante, R., Chen, M. P., Benator, D. A., Gordin, F., Benson, C. A., Chaisson, R. E., & Villarino, M. E. (2016). Three months of weekly rifapentine and isoniazid for treatment of mycobacterium tuberculosis infection in HIV-coinfected persons. AIDS, 30(10), 1607–1615. https://doi.org/10.1097/QAD.0000000000001098
- Sterling, T. R., Villarino, M. E., Borisov, A. S., Shang, N., Gordin, F., Bliven-Sizemore, E., Hackman, J., Hamilton, C. D., Menzies, D., Kerrigan, A., Weis, S. E., Weiner, M., Wing, D., Conde, M. B., Bozeman, L., Horsburgh, C. R., & Chaisson, R. E. (2011). Three months of rifapentine and isoniazid for latent tuberculosis infection. New England Journal of Medicine, 365(23), 2155–2166. https://doi.org/10.1056/NEJMoa1104875
- Stetler, C. B., Damschroder, L. J., Helfrich, C. D., & Hagedorn, H. J. (2011). A guide for applying a revised version of the PARIHS framework for implementation. Implementation Science, 6(1), 99. https://doi.org/10.1186/1748-5908-6-99
- Sunguya, B. F., Poudel, K. C., Mlunde, L. B., Shakya, P., Urassa, D. P., Jimba, M., & Yasuoka, J. (2013). Effectiveness of nutrition training of health workers toward improving caregivers’ feeding practices for children aged six months to two years: A systematic review. Nutrition Journal, 12(1), 66. https://doi.org/10.1186/1475-2891-12-66
- Suthar, A. B., Rutherford, G. W., Horvath, T., Doherty, M. C., & Negussie, E. K. (2014). Improving antiretroviral therapy scale-up and effectiveness through service integration and decentralization. AIDS, 28(Suppl 2), S175–S185. https://doi.org/10.1097/QAD.0000000000000259
- Swindells, S., Ramchandani, R., Gupta, A., Benson, C. A., Leon-Cruz, J., Mwelase, N., Jean Juste, M. A., Lama, J. R., Valencia, J., Omoz-Oarhe, A., Supparatpinyo, K., Masheto, G., Mohapi, L., da Silva Escada, R. O., Mawlana, S., Banda, P., Severe, P., Hakim, J., Kanyama, C., … Chaisson, R. E. (2019). One month of rifapentine plus isoniazid to prevent HIV-related tuberculosis. New England Journal of Medicine, 380(11), 1001–1011. https://doi.org/10.1056/NEJMoa1806808
- Sylla, L., Bruce, R. D., Kamarulzaman, A., & Altice, F. L. (2007). Integration and co-location of HIV/AIDS, tuberculosis and drug treatment services. International Journal of Drug Policy, 18(4), 306–312. doi:S0955-3959(07)00085-0 [pii] https://doi.org/10.1016/j.drugpo.2007.03.001
- Szakacs, T. A., Wilson, D., Cameron, D. W., Clark, M., Kocheleff, P., Muller, F. J., & McCarthy, A. E. (2006). Adherence with isoniazid for prevention of tuberculosis among HIV-infected adults in South Africa. BMC Infectious Diseases, 6(1), 97. https://doi.org/10.1186/1471-2334-6-97
- Tadesse, Y., Yesuf, M., & Williams, V. (2013). Evaluating the output of transformational patient-centred nurse training in Ethiopia. The International Journal of Tuberculosis and Lung Disease, 17(10 Suppl 1), 9–14. https://doi.org/10.5588/ijtld.13.0386
- Teklay, G., Teklu, T., Legesse, B., Tedla, K., & Klinkenberg, E. (2016). Barriers in the implementation of isoniazid preventive therapy for people living with HIV in northern Ethiopia: A mixed quantitative and qualitative study. BMC Public Health, 16(1), 840. https://doi.org/10.1186/s12889-016-3525-8
- Van Ginderdeuren, E., Bassett, J., Hanrahan, C., Mutunga, L., & Van Rie, A. (2019). Health system barriers to implementation of TB preventive strategies in South African primary care facilities. PloS one, 14(2), e0212035. https://doi.org/10.1371/journal.pone.0212035
- Van Halsema, C. L., Fielding, K. L., Chihota, V. N., Russell, E. C., Lewis, J. J., Churchyard, G. J., & Grant, A. D. (2010). Tuberculosis outcomes and drug susceptibility in individuals exposed to isoniazid preventive therapy in a high HIV prevalence setting. AIDS, 24(7), 1051–1055. https://doi.org/10.1097/QAD.0b013e32833849df
- Vella, V., Govender, T., Dlamini, S., Taylor, M., Moodley, I., David, V., & Jinabhai, C. (2010). Retrospective study on the critical factors for retaining patients on antiretroviral therapy in KwaZulu-Natal, South Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes, 55(1), 109–116. https://doi.org/10.1097/QAI.0b013e3181e7744e
- White, R., Charalambous, S., Cardenas, V., Hippner, P., Sumner, T., Bozzani, F., Mudzengi, D., Houben, R. M. G. J., Collier, D., Kimerling, M. E., Vassall, A., Pillay, Y., & Churchyard, G. (2018). Evidence-informed policy making at country level: Lessons learned from the South African Tuberculosis Think tank. The International Journal of Tuberculosis and Lung Disease, 22(6), 606–613. https://doi.org/10.5588/ijtld.17.0485
- Wilunda, C., Scanagatta, C., Putoto, G., Montalbetti, F., Segafredo, G., Takahashi, R., Mizerero, S. A., & Betrán, A. P. (2017). Barriers to utilisation of antenatal care services in South Sudan: A qualitative study in Rumbek North county. Reproductive Health, 14(1), 65. https://doi.org/10.1186/s12978-017-0327-0
- Witter, S., Fretheim, A., Kessy, F. L., & Lindahl, A. K. (2012). Paying for performance to improve the delivery of health interventions in low- and middle-income countries. Cochrane Database of Systematic Reviews, 2, Cd007899. https://doi.org/10.1002/14651858.CD007899.pub2
- World Health Organization. (2008). WHO Three I's Meeting.
- World Health Organization. (2013). Global Tuberculosis Report 2013.
- World Health Organization. (2018). Global Tuberculosis Report 2018.
- World Health Organization. (2020). WHO consolidated guidelines on tuberculosis. Tuberculosis preventive treatment. Geneva.
- Zaeh, S., Kempker, R., Stenehjem, E., Blumberg, H. M., Temesgen, O., Ofotokun, I., & Tenna, A. (2013). Improving tuberculosis screening and isoniazid preventive therapy in an HIV clinic in Addis Ababa, Ethiopia. The International Journal of Tuberculosis and Lung Disease, 17(11), 1396–1401. https://doi.org/10.5588/ijtld.13.0315
- Zurawski, A., Komaromy, M., Ceballos, V., McAuley, C., & Arora, S. (2016). Project ECHO brings innovation to community health Worker training and support. Journal of Health Care for the Poor and Underserved, 27(4a), 53–61. https://doi.org/10.1353/hpu.2016.0186